Infection Control and Biosafety Products | Global Markets

57 Pages | 13 Exhibits | 2019 Analysis | Forecasts Through 2023
Buy Now
Become Market Insider

Overview

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the healthcare-associated infection (HAI) prevention products and services market (medical waste disposal products and services, single-patient-use [SPU] medical device reprocessing systems, sharps disposal products, and sterilization equipment and services), injection devices market (standard and safety needles and syringes), and viral and bacterial diagnostic products market.

INFECTION CONTROL MARKET HIGHLIGHTS

  • Each year, HAIs affect nearly 700,000 people in the US and 4.5 million in Europe, resulting in billions of dollars in direct and indirect healthcare costs.
  • In 2018, combined global sales of the injection devices covered by this analysis totaled $2.7bn, with safety needles and syringes accounting for nearly 90% of sales; this share is expected to increase over the forecast period as the trend toward sharps with safety features continues.
  • The viral diseases covered by this report (hepatitis B, hepatitis C, and HIV) account for nearly 365 million infections globally, and nearly 8.5 million in the US, five major EU markets, and Japan.
  • From an infection control perspective, sterile-packaged SPU products offer the best assurance of avoiding infection; however, due to pricing pressures as a result of managed care, facilities must evaluate their mix of SPU and reusable devices.

 

KEY QUESTIONS ANSWERED

  • What are the key drivers and limiters to the infection control and biosafety products market?
  • Which competitors are leading the market and introducing new technology?
  • How are technological advancements impacting market growth?
  • Which areas of the infection control products market are experiencing dynamic growth?
  • How are mergers and acquisitions affecting the markets shares of leading competitors?

Table of Contents

Executive Summary 

i. HAI prevention products and services

ii. Injection devices and related products

iii. Viral and bacterial diagnostic products

iv. Methodology 

 

Exhibit ES-1: Injection devices, market forecast ($m), by product type, 2018-23

Exhibit ES-2: Bacterial infections, disease facts, latest year available

Exhibit ES-3: Viral infections, disease prevalence, 2018

 

1. Healthcare-Associated Infection Prevention Products and Services

1.1 Medical waste disposal products and services

1.1.1 Competitors 

1.2 Single patient use medical device reprocessing services

1.2.1 Competitors 

1.3 Other HAI prevention products and services

1.3.1 Sharps disposal containers

1.3.2 Sterilization equipment, services, and supplies

1.4 Bibliography 

 

2. Injection Devices

2.1 Overview 

2.2 Regulations and guidelines

2.3 Needlestick prevention

2.4 Standard disposable needles and syringes

2.4.1 Market analysis

2.4.2 Competitive analysis

2.5 Safety needles and syringes

2.5.1 Market analysis

2.5.2 Competitive analysis

2.6 Combined market forecast 

2.7 Bibliography 

 

Exhibit 2-1: Standard disposable needles and syringes, market forecast ($m), by region, 2018-23

Exhibit 2-2: Becton Dickinson, revenues by segment, 2018

Exhibit 2-3: Cardinal Health, revenues by segment, 2018

Exhibit 2-4: Smiths Group, revenues by segment, 2018

Exhibit 2-5: Standard disposable needles and syringes market, share by supplier, 2018

Exhibit 2-6: Safety needles and syringes, market forecast ($m), by region, 2018-23 

Exhibit 2-7: Safety needles and syringes market, share by supplier, 2018

Exhibit 2-8: Injection devices, combined market forecast ($m), by product type, 2018-23

 

3. Viral and Bacterial Diagnostic Products

3.1 Bacterial infectious disease diagnosis

3.1.1 Clostridium difficile 

3.1.2 Pneumonia

3.1.3 Staphylococcus aureus

3.1.4 Tuberculosis

3.2 Viral infectious disease diagnosis

3.2.1 Hepatitis B

3.2.2 Hepatitis C

3.2.3 Human immunodeficiency virus

3.3 Bibliography 

 

Exhibit 3-1: Bacterial infections, disease facts, latest year available

Exhibit 3-2: Viral infections, disease prevalence, 2018

 

Appendix: Company Listing

Companies Covered

3M Health Care/3M

Abbott Laboratories

Aesculap/B. Braun Melsungen AG

Air-Tite Products Co., Inc.

Alere, Inc.

Becton, Dickinson and Company

Bemis Manufacturing Company

bioMérieux SA

Bio-Rad Laboratories, Inc.

Cardinal Health, Inc.

Cepheid, Inc.

ChemBio Diagnostics Systems, Inc.

CR Bard, Inc.

Halyard Health, Inc.

Innovative Health, Inc.

Medline ReNewal/Medline Industries, Inc.

Medtronic Minimally Invasive Therapies/Medtronic PLC

Meridian Bioscience, Inc.

Nipro Medical Corporation

OraSure Technologies, Inc.

Oxford Immunotec, Inc.

Quidel Corporation

Retractable Technologies, Inc.

Roche Diagnostics/F. Hoffman-La Roche LTD

Sharps Compliance, Inc.

Siemens Healthineers/Siemens AG

Smiths Medical/Smiths Group

Sol-Millennium Medical Group

Stericycle, Inc.

Sterilmed, Inc./Johnson & Johnson

Stryker Corporation

Terumo Medical Corporation/Terumo Corporation

Thermo Fisher Scientific

Trinity Biotech PLC